[go: up one dir, main page]

EP0028644A1 - Impending ovulation test - Google Patents

Impending ovulation test

Info

Publication number
EP0028644A1
EP0028644A1 EP19800901141 EP80901141A EP0028644A1 EP 0028644 A1 EP0028644 A1 EP 0028644A1 EP 19800901141 EP19800901141 EP 19800901141 EP 80901141 A EP80901141 A EP 80901141A EP 0028644 A1 EP0028644 A1 EP 0028644A1
Authority
EP
European Patent Office
Prior art keywords
peroxidase
chromogenic substrate
test
vaginal fluid
fluid sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19800901141
Other languages
German (de)
French (fr)
Inventor
Gerald Oster
Albert S. Keston
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of EP0028644A1 publication Critical patent/EP0028644A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • C12Q1/28—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving peroxidase

Definitions

  • This invention relates to methods of detecting impending ovluation in human females, including methods which are sufficiently simple so that a woman can carry out the test on herself without the aid of a physician.
  • thermometry the basal body temperature method
  • a simple form of the invention contemplates the woman taking a sample of vaginal fluid with, for example, a moistened cotton swab and contacting the swab with a bibulous material comprising a substance which will cause a visible change in the presence of peroxidase and a peroxide. Such visible change could be a change in color or in luminescence.
  • the finding that the peroxidase is present in the vaginal fluid makes it.possible for a woman to readily obtain a sample with a moistened cotton swab with no harm to herself.
  • One of the preferred forms of the test involves the use of a paper comprising starch and an iodide salt which produces a blue color in the presence of a peroxidase when moistened with hydrogen peroxide.
  • the aforesaid test sheet will t rn blue.
  • Some of the means used in this invention detect both peroxidase and peroxidase-like substances, such as hemoglobin and its degradation products.
  • a simple method for the detection of impending ovulation in women, as in the present invention, is of the highest importance to the human race and is of paramount interest to such prestigious organizations as the Population Council, the Ford Foundation, the National Institutes of Health and the World Health Organ ⁇ ization.
  • the present invention a woman can, by herself, determine her impending fertile time.
  • the fertile time commences within 12 to 72 hours of ovulation (C. Tietze Fertility and Sterility, Vol. 11, p. 485, I960). ' By abstaining from coitus or by otherwise protecting herself from insemination during the fertile time a woman can avoid pregnancy.
  • this form of birth control could, if practiced widely, substantially reduce the rate of world-population growth.
  • a woman practicing abstinence during the fertile period as determined by the present invention may avoid the need for contraceptive devices, such as the intrauterine device, for birth control which are considered undesirable to some.
  • the present invention may also be an aid to couples who wish to have a child, but have failed because, for example, incorrect timing of coitus.
  • a preferred embodiment of the present invention uses a chromogenic substrate which responds rapidly to the estrogen-induced peroxidase of the vagina in the presence of a peroxide, but responds much more slowly to the action of hemoglobin or its degradation products.
  • Such chromogenic substrates are characterized by the fact that the rate constant (commonly designated k,; see B. Chance, Advances in Enzymology, 1951, Volume 12, pages 153-180) for the reaction of the substrate with the peroxidase-peroxidide complex exceeds about 10 moles " seconds .
  • Substrates having such high values of k. include, for example, p,p biphenol, hydro- quinone and 0-phenylenediamine. It should be noted that values of k. for a given chromogenic substance may differ somewhat with the choice of the particular hydroperoxide employed.
  • One of the preferred embodiments involves impreg ⁇ nating a bibulous strip of paper with an inorganic peroxide such as hydrogen peroxide, sodium peroxide, barium peroxide strontium peroxide, sodium perborate, and the like or an organic peroxide, such as methyl hydroperoxide, ethyl hydroperoxide, cumene hydroperoxide, dimethoxy dihydro- peroxy hexane, and the like.
  • Hydrogen peroxide may be considered both an inorganic ⁇ peroxrde and as a hydro- peroxide.
  • Chromogenic peroxidase substrates which may be employed in the present invention include the following substances:
  • -Mo ⁇ oamines such an aniline and its derivatives, orthotoluidine, para-toluidine, etc.
  • Diamines such as ortho-phenylenediamine
  • Nadi reagent producing a bluish color
  • bilirubin producing a greenish color
  • iodides which produce a brown color and, if starch is present, produce a deep blue color which is much stronger than iodide alone
  • Nadi reagent is such a mixture, namely naphthol and p-phenylenediamine, which gives a better final color than the individual components.
  • Another example is a mixture of 4-amino antipyrine and 1,7 dihydroxynaphthaline.
  • chromogens notably benzidine and its derivatives give a more intense color if halogen ions, such as iodide and bromide ions, or if halogenoid ions, . such as thiocyanate and selenocynate ions, are present.
  • halogen ions such as iodide and bromide ions
  • halogenoid ions such as thiocyanate and selenocynate ions
  • One of the preferred embodiments of the invention comprises 3,3', 5,5' tetramethyl benzidine and potassium thiocyanate; this mixture yields an intense blue color in a positive test.
  • Substrates which change their fluorescence in the presence of a peroxidase and hydrogen peroxide include a loss of fluorescence of scopoletin or a production of fluorescence with, for example, dichlorofluorescin or homovanillic acid. Chemiluminescence is produced in the presence of peroxidases and hydrogen peroxide for the following typical substances, luminol, zinc tetra phenylporphyrine and the like.
  • the color forming substance may undergo color change, not as a result of the direct action of a hydroperoxide, but by mediation through another compound which is acted upon by a hydroperoxide and does not itself become highly colored.
  • Examples of such color-forming or color-changing substances are:
  • Example 5 A woman who has regular menstrual cycles donated vaginal samples daily starting on day 5 of her cycle, where day 1 is taken as the day when menstruation began. The vaginal samples were obtained by the woman using a standard six inch cotton-tipped swab ("Puritan", Hardwood Products Co.). The cotton end was moistened with water and rolled gently on the wall of the anterior vagina. The vaginal sample on the swab was divided into six parts, each part of which was kept moistened.
  • OMPI Example 2 A portion of daily vaginal sample as described in example 1 was dipped into a 0.01% aqueous solution of orthotolidine (made up by diluting a 1% ethanolic solution of ortho- tolidine with 0.01 molar phosphate buffer at pH 6.5) and then dipped into a 0.005% solution of hydrogen per ⁇ oxide. Vaginal samples of days 5 through 8 gave no color (i.e. a negative test) but samples of days 9 and 10 gave a strong color (i.e. a positive test). Here again the test presumably anticipated ovulation.
  • orthotolidine made up by diluting a 1% ethanolic solution of ortho- tolidine with 0.01 molar phosphate buffer at pH 6.5
  • chromogenic substrates such as guaiac, p,p' biphenol or 3,3' 5,5' tetramethylbenzidine.
  • Said o-tolidine, p,p' biphenol or tetramethylbenzidine solutions may also comprise a bromide, iodide or thiocyanate.
  • a bibulous mat for example paper, comprising them may be employed. After contact with the swab comprising the vaginal sample the bibulous mat is moistened with hydrogen peroxide to produce the color indication if peroxidase is present.
  • dichlorfluorescein in place of ortho-tolidine but now a positive test is a strong yellow fluorescence (as obs-erved imder Wood's Lamp illumination) while no or only weak fluorescence is a negative test.
  • Example 3 A portion of the daily vaginal sample as described in example 1 was subjected to the commercially-available "Hematest" test for occult blood (Ames Company) .
  • the vaginal sample is applied to the bibulous white paper provided, to which a moistened pill containing, according to the manufacturer, ortho-tolidine, strontium peroxide, calcium acetate and tartaric acid is contacted.
  • Vaginal samples of days 5 through 8 gave no color or only weak
  • Example 4 A portion of the daily vaginal sample as described in example 1 was subjected to the occult blood test portion of the commercially-available "N-Multistix" (Ames Company) . According to the manufacturer this portion of the test stick contains ortho-tolidine and cumene hydroperoxide. The test stick gave no or only weak coloration for vaginal samples of days 5 through 8, but gave a strong blue coloration for samples of days 9 and 10. Here again the test presumably anticipated ovulation.
  • a portion of the daily vaginal samples as described in example 1 was subjected to the commercially-available "He occult" occult blood test for feces (Smith Kline and French Laboratories) . According to the manufacturer this consists of a bibulous paper impregnated with an ethanolic solution of guaiac and allowed to dry. The vaginal samples were contacted with " this test paper and then a 0.1% ethanolic solution of hydrogen peroxide was added. The test paper gave no or only weak coloration for vaginal samples of days 5 through 8, but gave a • strong blue coloration for samples of days 9 and 10. Here again the test presumably anticipated ovulation.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Procede de detection d'une ovulation imminente chez la femme utilisant des moyens utilisables par une personne normale. Le procede d'essai consiste a mettre en contact des echantillons de fluides vaginaux avec des substances chimiques qui indiquent la presence de peroxydases dans les echantillons de fluides vaginaux, par exemple, un substrat chromogene d'une peroxydase melangee avec un hydroperoxyde.Method for detecting imminent ovulation in women using means usable by a normal person. The test method involves contacting samples of vaginal fluids with chemicals that indicate the presence of peroxidases in samples of vaginal fluids, for example, a chromogenic substrate of a peroxidase mixed with a hydroperoxide.

Description

Description
Impending Ovulation Test
Technical Field
This invention relates to methods of detecting impending ovluation in human females, including methods which are sufficiently simple so that a woman can carry out the test on herself without the aid of a physician.
Background Art
While prior methods of fertility or ovulation testing have been proposed, prior tests have one or more unde¬ sirable aspects. For example, in the prior art the method of utilizing thermometry (the basal body temperature method) provides information on fertility, but this test merely indicates that ovulation has already occurred and does not detect impending ovulation.
The prior ovulation detection methods involving an examination of cervical mucus for its flow properties, saline content, glucose content and the like, are also deficient in that they do not easily lend themselves to self--examination by the woman and require sampling of portions of the vagina. Similarly, microscopic exami¬ nation of vaginal cells for staining characteristics and morphology require expensive apparatus and involve techniques which are usually beyond the skill of the average woman. Estrogen analysis of blood and urine is likewise complicated and difficult to carry out.
Means for peroxidase testing have been known since 1898. Such means have been used for over 75 years for the detection of blood, including commercial articles sold, for "example, by Smith -Kline and French Laboratories and by Miles Laboratories, for the detection of occult blood in urine and feces. Despite the long history of the peroxidase test it has not been previously used to determine the surge in estrogen-induced peroxidase in vaginal fluid for the detection of impending ovulation. This may be due to the fact that pathological conditions or injuries resulting in blood being present in the vagina contribute to a false positive indication for estrogen-induced peroxidase. It is known that hemoglobin and its degradation products exhibit a peroxidase-like reaction and, indeed, this property is utilized in the occult blood test for urine and feces.
Disclosure of Invention
In the approximately two to three days prior to ovulation in the menstrual cycle of normal human females there is a surge in the amount of estrogen-induced peroxi- dase in the vaginal fluid. A simple form of the invention contemplates the woman taking a sample of vaginal fluid with, for example, a moistened cotton swab and contacting the swab with a bibulous material comprising a substance which will cause a visible change in the presence of peroxidase and a peroxide. Such visible change could be a change in color or in luminescence. The finding that the peroxidase is present in the vaginal fluid makes it.possible for a woman to readily obtain a sample with a moistened cotton swab with no harm to herself. One of the preferred forms of the test involves the use of a paper comprising starch and an iodide salt which produces a blue color in the presence of a peroxidase when moistened with hydrogen peroxide. When peroxidase is present in the vaginal fluid the aforesaid test sheet will t rn blue.
Some of the means used in this invention detect both peroxidase and peroxidase-like substances, such as hemoglobin and its degradation products.
υR
OM $ 1P Best Mode For Carrying Out the Invention
A simple method for the detection of impending ovulation in women, as in the present invention, is of the highest importance to the human race and is of paramount interest to such prestigious organizations as the Population Council, the Ford Foundation, the National Institutes of Health and the World Health Organ¬ ization. With the present invention a woman can, by herself, determine her impending fertile time. There is extensive clinical evidence that for women the fertile time commences within 12 to 72 hours of ovulation (C. Tietze Fertility and Sterility, Vol. 11, p. 485, I960).' By abstaining from coitus or by otherwise protecting herself from insemination during the fertile time a woman can avoid pregnancy. Thus with the aid of the present invention which enables a woman to determine her fertile time, this form of birth control could, if practiced widely, substantially reduce the rate of world-population growth. Using the present invention one may practice birth control without interference with the normal female hormonal function, such as occurs with the contraceptive pill which is objectionable to certain segments of the world population on religious grounds, as well as to others on medical grounds due to the possible serious side effects. A woman practicing abstinence during the fertile period as determined by the present invention may avoid the need for contraceptive devices, such as the intrauterine device, for birth control which are considered undesirable to some. The present invention may also be an aid to couples who wish to have a child, but have failed because, for example, incorrect timing of coitus. Thus it may be seen that because the present invention can be a valuable aid in family planning, it serves an- important humanitarian purpose. - A preferred embodiment of the present invention uses a chromogenic substrate which responds rapidly to the estrogen-induced peroxidase of the vagina in the presence of a peroxide, but responds much more slowly to the action of hemoglobin or its degradation products. Such chromogenic substrates are characterized by the fact that the rate constant (commonly designated k,; see B. Chance, Advances in Enzymology, 1951, Volume 12, pages 153-180) for the reaction of the substrate with the peroxidase-peroxidide complex exceeds about 10 moles" seconds . Substrates having such high values of k. include, for example, p,p biphenol, hydro- quinone and 0-phenylenediamine. It should be noted that values of k. for a given chromogenic substance may differ somewhat with the choice of the particular hydroperoxide employed.
One of the preferred embodiments involves impreg¬ nating a bibulous strip of paper with an inorganic peroxide such as hydrogen peroxide, sodium peroxide, barium peroxide strontium peroxide, sodium perborate, and the like or an organic peroxide, such as methyl hydroperoxide, ethyl hydroperoxide, cumene hydroperoxide, dimethoxy dihydro- peroxy hexane, and the like. Hydrogen peroxide may be considered both an inorganic <peroxrde and as a hydro- peroxide. Many compounds, for example sodium peroxide, barium peroxide, strontium peroxide, sodium perborate, and the bis (1-hydroxyalkyl) peroxides generate hydrogen peroxide when moistened. Enzymatic reactions such as the action in air of L-amino oxidase on L-amino acids also generate hydrogen peroxide.
Chromogenic peroxidase substrates which may be employed in the present invention include the following substances:
1) -Moπoamines, such an aniline and its derivatives, orthotoluidine, para-toluidine, etc.; 2) Diamines, such as ortho-phenylenediamine,
N,N dimethylpara-phenylenediamine, N,N diethyl- phenylenediamine, benzidine, 3,3', 5,5', tetra- methyl benzidine, dianisidine, o-tolidine, etc.; 3) Phenols, such as phenol per se, thymol, ortho, meta and para-cresols, alpha-napthol, p,ρ- dihydroxybiphenyl, phloroglucinol and guaiacol; 4) Aromatic acids, such as salicylic, pyrocatechuic and gallic acids; 5) Leucodyes, such as leucomalachite green (to produce malachite green) and leucophenolphthalein (desirably employed in a alkaline medium) ; 6) Colored dyes, such as 2,6 dichlorophenol indo- phenol; 7) Various biological substances, such as epinephine, the flavones, tyrosine, dihydrophenylalanine (producing an orange-reddish color) and trypto- phane. Other substances such as gum guaiac, guaiaconic acid, Nadi reagent (producing a bluish color) , bilirubin (producing a greenish color) , iodides (which produce a brown color and, if starch is present, produce a deep blue color which is much stronger than iodide alone) . Some of the substances may be most effectively used in combination rather than individually. For example, Nadi reagent is such a mixture, namely naphthol and p-phenylenediamine, which gives a better final color than the individual components. Another example is a mixture of 4-amino antipyrine and 1,7 dihydroxynaphthaline. Many of the chromogens, notably benzidine and its derivatives give a more intense color if halogen ions, such as iodide and bromide ions, or if halogenoid ions, . such as thiocyanate and selenocynate ions, are present. One of the preferred embodiments of the invention comprises 3,3', 5,5' tetramethyl benzidine and potassium thiocyanate; this mixture yields an intense blue color in a positive test.
Substrates which change their fluorescence in the presence of a peroxidase and hydrogen peroxide include a loss of fluorescence of scopoletin or a production of fluorescence with, for example, dichlorofluorescin or homovanillic acid. Chemiluminescence is produced in the presence of peroxidases and hydrogen peroxide for the following typical substances, luminol, zinc tetra phenylporphyrine and the like.
The color forming substance may undergo color change, not as a result of the direct action of a hydroperoxide, but by mediation through another compound which is acted upon by a hydroperoxide and does not itself become highly colored. Examples of such color-forming or color-changing substances are:
1) Starch and potassium iodide to produce the characteristic starch-iodine purple which is stronger in color than iodide alone produces. 2) Mixture of a ferrous salt, such as ferrous ammonium sulfate, and tannic acid to produce a dark color.
3) Mixture of potassium iodide and 3,3', 5,5' te-tramethyl 'benzidine to produce a blue-black color stronger than either one alone.
4) Mixture of potassium thiocyanate and o-tolidine forming a blue color stronger than o-tolidine alone.
5) Mixture of potassium thiocyanate and p, p1 biphenol forming a black color stronger than p,p' biphenol alone. Hereinafter such mixtures will also be referred to as chromogenic substrates of peroxidase, even if the mixture does not undergo -a color -change as a result of the direct action of a hydroperoxide. Example 1 A woman who has regular menstrual cycles donated vaginal samples daily starting on day 5 of her cycle, where day 1 is taken as the day when menstruation began. The vaginal samples were obtained by the woman using a standard six inch cotton-tipped swab ("Puritan", Hardwood Products Co.). The cotton end was moistened with water and rolled gently on the wall of the anterior vagina. The vaginal sample on the swab was divided into six parts, each part of which was kept moistened.
One portion of the daily sample was contacted with commercially-available starch-iodide test paper (Precision Laboratories) and on the paper was placed a drop of dilute aqueous hydrogen peroxide solution having a concen- tration of 0.005%. A postive test was indicated by the formation of a strong blue color in about 2 minutes. A negative test was indicated if no color or only weak color was produced in about 2 minutes.
For the woman tested the test was negative for the samples of days 5 through 8, but on days 9 and 10 a strong blue color (i.e. positive color) was obtained. On this same woman tests of lutenizing hormone (LH) were taken on daily samples of her urine and it was found that a surge in LH occurred on day 12. She reported that her cerival mucus felt slippery (the Billing Test) at days 11 and 12 and that her basal body temperature (BBT) rose on day 14. The woman started to menstruate on day 27. The test for peroxidase herein described occurred at a time consistent with the other tests and therefore the positive peroxidase result anticipated ovulation; ovulation presumably occurring on or about day 13.
OMPI Example 2 A portion of daily vaginal sample as described in example 1 was dipped into a 0.01% aqueous solution of orthotolidine (made up by diluting a 1% ethanolic solution of ortho- tolidine with 0.01 molar phosphate buffer at pH 6.5) and then dipped into a 0.005% solution of hydrogen per¬ oxide. Vaginal samples of days 5 through 8 gave no color (i.e. a negative test) but samples of days 9 and 10 gave a strong color (i.e. a positive test). Here again the test presumably anticipated ovulation.
In place of ortho-tolidine a number of chromogenic substrates may be used, such as guaiac, p,p' biphenol or 3,3' 5,5' tetramethylbenzidine. Said o-tolidine, p,p' biphenol or tetramethylbenzidine solutions may also comprise a bromide, iodide or thiocyanate. Instead of solutions of the above chromogenic substrates, a bibulous mat, for example paper, comprising them may be employed. After contact with the swab comprising the vaginal sample the bibulous mat is moistened with hydrogen peroxide to produce the color indication if peroxidase is present.
One may also use dichlorfluorescein in place of ortho-tolidine but now a positive test is a strong yellow fluorescence (as obs-erved imder Wood's Lamp illumination) while no or only weak fluorescence is a negative test.
Example 3 A portion of the daily vaginal sample as described in example 1 was subjected to the commercially-available "Hematest" test for occult blood (Ames Company) . The vaginal sample is applied to the bibulous white paper provided, to which a moistened pill containing, according to the manufacturer, ortho-tolidine, strontium peroxide, calcium acetate and tartaric acid is contacted. Vaginal samples of days 5 through 8 gave no color or only weak
_ O color, but samples of days 9 and 10 gave a strong blue color. Here again the test presumably anticipated ovu¬ lation.
Example 4 A portion of the daily vaginal sample as described in example 1 was subjected to the occult blood test portion of the commercially-available "N-Multistix" (Ames Company) . According to the manufacturer this portion of the test stick contains ortho-tolidine and cumene hydroperoxide. The test stick gave no or only weak coloration for vaginal samples of days 5 through 8, but gave a strong blue coloration for samples of days 9 and 10. Here again the test presumably anticipated ovulation.
Example 5
A portion of the daily vaginal samples as described in example 1 was subjected to the commercially-available "He occult" occult blood test for feces (Smith Kline and French Laboratories) . According to the manufacturer this consists of a bibulous paper impregnated with an ethanolic solution of guaiac and allowed to dry. The vaginal samples were contacted with "this test paper and then a 0.1% ethanolic solution of hydrogen peroxide was added. The test paper gave no or only weak coloration for vaginal samples of days 5 through 8, but gave a • strong blue coloration for samples of days 9 and 10. Here again the test presumably anticipated ovulation.
BU R£4
OMPI . ~WΪP0~ Λ,
Φ?NATIO^

Claims

Claims
1. A method for detecting impending ovulation in human females comprising a test for peroxidase in a vaginal fluid sample.
5 2. A method according to claim 1 in which said test for peroxidase produces a color change.
3. A method according to claim 1 in which said test for peroxidase produces a change in luminescence.
4. A method according to claim 1 where the test for o peroxidase comprises treating a vaginal fluid sample with a chromogenic substrate of peroxidase and a hydroperoxide-.
5. A method according to claim 4 where the test for peroxidase comprises contacting vaginal fluid with an inorganic peroxide.
6. A method according to claim 1 where the test for peroxidase comprises contacting the vaginal fluid sample with a bibulous mat comprising a chromogenic substrate of peroxidase.
7. A claim according to claim 1 where the test for peroxidase comprises contacting the vaginal fluid sample with a bibulous mat, said mat comprising a chromogenic substrate for peroxidase and a hydro¬ peroxide.
8. A claim according to claim 5 where the test for peroxidase comprises contacting a vaginal fluid sample with a chromogenic substrate for peroxidase and an inorganic peroxide in a pill.
9. A claim according to claim 6 where the chromogenic substrate of peroxidase is guaiac.
10. A claim according to claim 7 where the chromogenic substrate for peroxidase is O-tolidine and the hydroperoxide is cumene hydroperoxide
11. A claim according to claim 8 where the chromogenic substrate for peroxidase is O-tolidine and the inorganic peroxide is strontium peroxide.
12. A claim according to claim 4 where the vaginal fluid sample is absorbed on a bibulous material which has been in contact with the vagina.
13. A claim according to claim 4 where the chromogenic substrate is starch and a soluble iodide salt.
14. A claim according to claim 4 where the chromogenic substrate is guaiac.
15. A claim according to claim 4 where the chromogenic ssuubbssttrraattee hhaass aa rraattee ccoonnssttaant k. (as defined herein) in excess of about 100,000.
" 16. A claim according to claim 4 where the chromogenic substrate is p,p' biphenol
17. A claim according to claim 4 -where the chromogenic substrate is ortho-tolidine and a soluble iodide salt.
18. A claim according to claim 4 where the chromogenic substrate is '3, ',5,'5' tetramethylbenzidine and a soluble iodide salt.
19. A claim according to claim 4 where the chromogenic substrate is 3,3' ,5,5' tetramethylbenzidine and a soluble bromide salt.
20. A claim according to clain 4 where the chromogenic substrate is 3,3' ,5,5' tetramethylbenzidine and a soluble thiocyanate salt.
21. A claim according to claim 4 where the chromogenic substrate is orthodianisidine and a soluble iodide salt.
22. A claim according to claim 4 where the chromogenic substrate changes its luminescence after oxi.dation by peroxide in the presence of peroxidase.
23. A claim according to claim 4 where the hydroperoxide is hydrogen peroxide.
24. A claim according to claim 4 where the hydroperoxide is cumene hydroperoxide.
25. A claim according to claim 4 where the chromogenic substrate is a mixture of p,p' biphenol and a soluble thiocyanate salt.
26. A method according to claim 12 where the bibulous mat which has been in contact with the vagina com¬ prises a chromogenic substrate for peroxidase.
27. A claim according to claim 26 where the chromogenic substrate for peroxidase is guaiac.
28. A claim according to claim 26 where the chromogenic substrate for peroxidase is bilirubin.
29. A claim according to claim 7 where the chromogenic substrate is o-tolidine and the hydroperoxide is dimethoxy dihydroperoxy hexane.
30. A claim according to claim 1 where the test for peroxidase comprises contacting a vaginal fluid sample with a compound which generates hydrogen peroxide.
31. A claim according to claim 1 where the test for peroxidase comprises contacting a vaginal fluid sample with an enzyme-substrate system which gen¬ erates hydrogen peroxide.
EP19800901141 1979-05-16 1980-12-01 Impending ovulation test Withdrawn EP0028644A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3927379A 1979-05-16 1979-05-16
US39273 1979-05-16

Publications (1)

Publication Number Publication Date
EP0028644A1 true EP0028644A1 (en) 1981-05-20

Family

ID=21904589

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19800901141 Withdrawn EP0028644A1 (en) 1979-05-16 1980-12-01 Impending ovulation test

Country Status (2)

Country Link
EP (1) EP0028644A1 (en)
WO (1) WO1980002596A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4614715A (en) * 1982-05-14 1986-09-30 The Board Of Trustees Of The University Of Illinois Predictive test for impending ovulation in mammals
IL71699A0 (en) * 1983-05-02 1984-07-31 Enzo Biochem Inc Methods and kits for the analysis and detection of biological or genetic material
US4615972A (en) * 1983-11-04 1986-10-07 Immuno Concepts, Inc. Stabilization of indicators for detecting enzyme activity
ZA862671B (en) * 1985-05-06 1986-11-26 Richardson Vicks Inc Diagnostic saliva test for detecting periodontal disease
FR2652092A1 (en) * 1989-09-15 1991-03-22 Fama Process for measuring the peroxidase activity of cervical glairy mucus
FR2677126B1 (en) * 1991-05-27 1994-06-03 Fama Sa REAGENT FOR MEASURING THE PEROXYDASIC ACTIVITY OF CERVICAL MECHANISM, DEVICE FOR IMPLEMENTING THIS REAGENT AND METHOD FOR PRODUCING THE SAME.
MXPA01010950A (en) * 1999-04-26 2002-05-06 Procter & Gamble A blood detection composition.
CN1099465C (en) * 1999-08-25 2003-01-22 彭晓虹 Ovulation detection kit for natural contraception and manufacturing method thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA854156A (en) * 1970-10-20 O. Foster Raymond Test tape and method for detecting peroxidase
US3472738A (en) * 1967-06-12 1969-10-14 Weston Lab Inc Test implement for detecting peroxidase

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO8002596A1 *

Also Published As

Publication number Publication date
WO1980002596A1 (en) 1980-11-27

Similar Documents

Publication Publication Date Title
US4340669A (en) System for the determination of glucose in fluids
US4391905A (en) System for the determination of glucose in fluids
US4391906A (en) System for the determination of glucose in fluids
US4333734A (en) Diagnostic device for fecal occult blood and method of use
DE69527361T2 (en) COLOR COUPLER FOR SPECTROPHOTOMETRIC DETERMINATION OF ANALYZES
US3968011A (en) Test implement and test method for colorimetrically determining whether a female is fertile or pregnant
US4673654A (en) Composition for determining peroxidase-like activity of hemoglobin
KR100247941B1 (en) Composition, kit and method for detecting helicobacter pylori in biopsies
FI58943C (en) FOERFARANDE FOER SAMTIDIG ELLER ENSKILD BESTAEMNING AV LAKTATDEHYDROGENASERNAS ISOENZYMER
DK156667B (en) METHOD AND TEST MATERIAL FOR DETERMINING THE EXISTENCE OF GLUCOSE IN A TEST
EP0028644A1 (en) Impending ovulation test
US4724204A (en) Diagnostic device for the detection of increased dehydrogenase or oxidase and the use thereof
EP0074505B1 (en) Fertility indicator system
US3699005A (en) Method and article for detecting the fertile period
DE3851304T2 (en) Method and test composition for the determination of enzyme activity.
US3116223A (en) Method for detecting the presence of glucose in cervical mucus
EP0030560A1 (en) Specific impending ovulation indicator
US5981291A (en) Estrogen marker system
US5922613A (en) Method for evaluating estrogen dependent physiological conditions
Toates The forensic identification of semen by isoelectric focusing of seminal acid phosphatase
CA1276531C (en) Diagnostic saliva test for detecting periodontal disease
Furiya et al. Estimation of serum β-acetylaminodeoxyglucosidase
CN121141630A (en) Detection reagent and detection kit for acetylglucosaminidase and application of detection reagent and detection kit
MXPA97006716A (en) Chemical time regulator for pru reagent visual strip

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Designated state(s): AT CH DE FR GB LU NL SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19810518